These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 23161317

  • 21. [Cutaneous necrosis due to injection of interferon-alpha 2b in a patient with chronic hepatitis C].
    Castellanos González M, Pérez Carreras M, Muñoz Gómez R, Castellano Tortajada G.
    Gastroenterol Hepatol; 2011 Oct; 34(8):584-5. PubMed ID: 21641684
    [No Abstract] [Full Text] [Related]

  • 22. [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C].
    Abellán Galiana P, Pérez-Lázaro A, Aguilera Sancho-Tello V, Merino Torres JF, Berenguer Haym M, Piñón Sellés F.
    Endocrinol Nutr; 2009 Mar; 56(3):136-9. PubMed ID: 19627727
    [Abstract] [Full Text] [Related]

  • 23. Autoimmune fulminant hepatic failure in chronic hepatitis C during Peg-interferon-alpha 2b plus ribavirin treatment showing histological heterogeneity.
    Yasui S, Fujiwara K, Yokosuka O.
    Dig Liver Dis; 2011 Aug; 43(8):666-7. PubMed ID: 21435960
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Sarcoidosis induced by therapy with pegylated interferon alfa-2a].
    Bruch-Gerharz D, Reifenberger J.
    Hautarzt; 2006 Apr; 57(4):317-35. PubMed ID: 16523277
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Interferon-α induced lupus in a patient with chronic hepatitis C virus.
    Rizvi R, Hojjati M.
    J Clin Rheumatol; 2011 Apr; 17(3):152-3. PubMed ID: 21441813
    [No Abstract] [Full Text] [Related]

  • 30. [Early interruption of triple therapy with telaprevir in chronic hepatitis C due to severe adverse effects does not necessarily lead to treatment failure].
    Virolés Torrent S, López Nuñez C, Hombrados Verde M, Figa Francesch M, Ferri Iglesias MJ, Louvriex Freire R, Acero Fernández D.
    Gastroenterol Hepatol; 2015 Feb; 38(2):78-81. PubMed ID: 24948444
    [No Abstract] [Full Text] [Related]

  • 31. Conquering hepatitis C, step by step.
    Schafer DF, Sorrell MF.
    N Engl J Med; 2000 Dec 07; 343(23):1723-4. PubMed ID: 11106723
    [No Abstract] [Full Text] [Related]

  • 32. Repeated Panniculitis Induced by Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis C.
    Song JS, Sohn JH, Jeong JY, Min JH, Choi WS, Kim OZ, Pyo JY.
    Korean J Gastroenterol; 2016 May 25; 67(5):272-276. PubMed ID: 27206440
    [Abstract] [Full Text] [Related]

  • 33. Peripheral nervous system involvement in a haemodialysis patient treated with pegylated interferon.
    Ruiz-Fuentes MC, Rubert-Gómez De Quero A, De Gracia-Guindo C, Galindo-Sacristán P, Osuna-Ortega A.
    Nefrologia; 2012 May 25; 32(6):863-5. PubMed ID: 23169385
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Injection site with generalized rash caused by pegylated interferon alpha 2a injection.
    Kawada K, Maeda N, Kobayashi S, Sowa J, Tsuruta D, Kawada N.
    Dermatology; 2006 May 25; 212(1):82-3. PubMed ID: 16319482
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Type 1 diabetes developing during alpha-interferon therapy: report of two cases].
    Vinagre I, Rigla M, Torras X, Enríquez J, Corcoy R.
    Endocrinol Nutr; 2010 Oct 25; 57(8):393-5. PubMed ID: 20462813
    [No Abstract] [Full Text] [Related]

  • 40. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
    Demirturk N, Aykin N, Demirdal T, Cevik F.
    Eur J Dermatol; 2006 Oct 25; 16(5):579-80. PubMed ID: 17101483
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.